Cascadian Therapeutics Inc. (CASC): Seth Klarman Took A Victory Lap
Value investor Seth Klarman disclosed in a recent 13G filing that it tendered all of its 8.7 million stake in Cascadian Therapeutics Inc. (CASC).
Cascadian Therapeutics Inc. (CASC)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 0 | $0 | 0% | |
| 2. | D E Shaw D. E. Shaw | 0 | $0 | 0% | |
| 3. | VenBio Select Advisor Kurt Von Emster | 0 | $0 | 0% | |
| 4. | Tudor Investment Corp Paul Tudor Jones | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.74 | 5,500 | Officer, Director | 49,716 | 2017-08-11 | Filing | |
| $4.00 | 2,800 | Officer, Director | 44,216 | 2017-05-12 | Filing | |
| $4.11 | 2,000 | Officer, Director | 41,416 | 2017-03-31 | Filing | |
| $4.12 | 1,666 | Director | 3,332 | 2017-03-28 | Filing | |
| $3.93 | 1,000 | Officer, Director | 39,416 | 2017-03-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.72 | 3,403 | Director | 20,644 | 2013-07-10 | Filing | |
| $1.96 | 12,780 | Director | 24,047 | 2013-02-20 | Filing | |
| $8.74 | 28,900 | Large Shareholder | 2,985,238 | 2011-06-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Is Cascadian Therapeutics Inc (USA) (CASC) A Good Stock To Buy?
The successful funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research ...
Hedge Funds Are Dumping Cascadian Therapeutics Inc (USA) (CASC)
Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don...
Biotech Movers And Shakers: Cascadian Therapeutics Inc (USA) (CASC) And Anthera Pharmaceuticals Inc (ANTH)
Another day done in biotech, and we’re fast closing in on the end of the week.
Cascadian Therapeutics Inc. (CASC): Billionaire Seth Klarman’s Baupost Group Reports New Stake
Billionaire Seth Klarman’s Baupost Group recently reported a new stake in Cascadian Therapeutics Inc. (NASDAQ:CASC), in a 13G filing with the SEC.
Here is What Hedge Funds Think About Alamo Group, Inc. (ALG)
At the moment, there are a multitude of methods shareholders can use to analyze Mr. Market. Two of the most under-the-radar are hedge fund and insider trading activity.
Here is What Hedge Funds and Insiders Think About Columbus McKinnon Corp. (CMCO)
If you were to ask many of your fellow readers, hedge funds are viewed as useless, old investment vehicles of a period lost to current times.
Is NACCO Industries, Inc. (NC) Going to Burn These Hedge Funds?
In the eyes of many investors, hedge funds are assumed to be bloated, old financial tools of an era lost to time.
Do Hedge Funds and Insiders Love Lindsay Corporation (LNN)?
To many traders, hedge funds are viewed as overrated, old financial tools of a period lost to current times.
Alamo Group, Inc. (ALG): Are Hedge Funds Right About This Stock?
Alamo Group, Inc. (NYSE:ALG) was in 9 hedge funds' portfolio at the end of the first quarter of 2013. ALG investors should pay attention to an increase in hedge fund sentiment in recent months.
Billionaire Hedge Funds
